🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Akito Kawai

Fujita Health University

ORCID: 0000-0001-5695-8814

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 7 papers. Top paper: “Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in Enterobacter cloacae Complex Following Exposure to Cefepime”.

Clinical Evolution of AmpC-Mediated Ceftazidime-Avibactam and Cefiderocol Resistance in Enterobacter cloacae Complex Following Exposure to Cefepime

Clinical Infectious Diseases(2020)10.1093/cid/ciaa355

N/A

0.689DataRank · unranked

98 citations

Alina Iovleva, Ellen G Kline, Akito Kawai, Christi L. McElheny, Yohei Doi +1 more

Functional and Structural Characterization of Acquired 16S rRNA Methyltransferase NpmB1 Conferring Pan-Aminoglycoside Resistance

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.01009-21

N/A

0.505DataRank · unranked

28 citations

Masahiro Suzuki, Kentaro Tsukamoto, Y. Minato, Yohei Doi, Akito Kawai

Clinical and molecular landscape of prolonged SARS-CoV-2 infection with resistance to remdesivir in immunocompromised patients

PNAS Nexus(2025)10.1093/pnasnexus/pgaf085

N/A

0.373DataRank · unranked

11 citations

Takaya Ichikawa, Tomokazu Tamura, Mutsumi Takahata, Takashi Ishio, Makoto Ibata +25 more

In vitro evolution of durlobactam resistance in NDM-producing Escherichia coli due to a single mutation in mrdA encoding penicillin-binding protein 2

Antimicrobial Agents and Chemotherapy(2025)10.1128/aac.01014-25

N/A

0.208DataRank · unranked

3 citations

Erika L. Butcher, Akito Kawai, Robert M. Q. Shanks, Ryan K. Shields, Yohei Doi +1 more

High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated β-lactamase CMY-185 variant

Journal of Antimicrobial Chemotherapy(2023)10.1093/jac/dkad249

N/A

0DataRank · unranked

21 citations

Bradley T. Endres, Jovan Borjan, Samuel L Aitken, William C. Bachman, Christi L. McElheny +11 more

Structural Basis of Reduced Susceptibility to Ceftazidime-Avibactam and Cefiderocol in Enterobacter cloacae Due to AmpC R2 Loop Deletion

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.00198-20

N/A

0DataRank · unranked

84 citations

Christi L. McElheny, Alina Iovleva, Ellen G Kline, Nicolas Sluis‐Cremer, Ryan K. Shields +2 more

High-level ceftazidime-avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated beta-lactamase CMY-185 variant

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.02.03.527067

N/A

0DataRank · unranked

0 citations

Bradley T. Endres, Jovan Borjan, Samuel L Aitken, William C. Bachman, Christi L. McElheny +8 more